Vonoprazan Triple Therapy Most Cost-Effective for H pylori: Study Vonoprazan Triple Therapy Most Cost-Effective for H pylori: Study
In the United States, vonoprazan triple therapy has significant health and economic benefits relative to other first-line H pylori eradication regimens, with rifabutin triple therapy a close second.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - December 30, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

The Changes Made in the New Expert Consensus on H pylori The Changes Made in the New Expert Consensus on H pylori
With the last update published in 2017, current consensus, released in August 2022, covers most of the latest progress made in the management of the infection.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 15, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Eradicating H. pylori Cuts Aspirin-Related Peptic Ulcer Bleeding in the Short Term
MONDAY, Nov. 14, 2022 -- Eradication of Helicobacter pylori reduces the incidence of peptic ulcer bleeding in older adults receiving daily aspirin, but the advantage does not persist after the first 2.5 years of follow-up, according to a study... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 14, 2022 Category: General Medicine Source Type: news

What Are the Potential Benefits and Risks of Premasticated Foods?
Discussion Premastication is the prechewing of foods or medicines by another person before feeding to an infant. It is also used to pretaste or temperature test foods. It was a common practice for millennia, especially before modern food technology, as a way to transition an infant from a solely liquid based diet to a mixed diet mainly of solid food. Rates of premastication vary, with less developed countries having an increased incidence/prevalence (up to 50%) but it is not uncommon in developed countries (in the US 14% is reported). Saliva is also used to clean other people, treat cuts/itches or insect bites as well. Pla...
Source: PediatricEducation.org - November 14, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Time to Ditch Clarithromycin for H pylori? Time to Ditch Clarithromycin for H pylori?
High clarithromycin resistance rates among H pylori isolates in the United States and Europe are grounds for arguing against its use in PPI-based triple therapy, researchers say.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - October 21, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Antioxidant-Rich Diet May Reduce H pylori Risk Antioxidant-Rich Diet May Reduce H pylori Risk
These are the latest data suggesting that balanced diets high in fruits and vegetables may provide an antioxidant environment allowing the body to fight off H pylori.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 23, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

When Not to Skip H pylori Testing When Not to Skip H pylori Testing
A quick review of when, how, and why to test for Helicobacter pylori.The Curbsiders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 16, 2022 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

New German Guideline for H. pylori Infection Coming Soon New German Guideline for H. pylori Infection Coming Soon
The guideline will recommend for the first time that an infection be treated as soon as it is detected, regardless of whether the patient has symptoms.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - June 9, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

New GI Treatment Voquenza Approved For Helicobacter Pylori Infection; Other Indications May Follow
In May, FDA approved Voquenza (vonoprazan fumarate), in combination with anti-biotics, for H.pylori infection. In March, Phathom Pharmaceuticals submitted an NDA to FDA for the use of vonoprazan as a treatment for the healing of all grades of erosive reflux esophagitis and relief of heartburn. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 1, 2022 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

H pylori Antibiotics Briefly Disrupt Gut Microbiome H pylori Antibiotics Briefly Disrupt Gut Microbiome
Researchers compared antibiotic resistance following either levofloxacin quadruple therapy or bismuth quadruple therapy.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 27, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

H. pylori Infection  Often Detected in Patients With Dyspepsia
TUESDAY, May 24, 2022 -- In Northwest Ethiopia, 35 percent of patients with dyspepsia have peptic ulcer disease, with risk factors including Helicobacter pylori (H. pylori) infection and nonsteroidal anti-inflammatory drug (NSAID)/acetylsalicylic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 24, 2022 Category: Pharmaceuticals Source Type: news

H pylori May Undermine Immunotherapy Response in Gastric Cancer H pylori May Undermine Immunotherapy Response in Gastric Cancer
H pylori infection was associated with shorter progression-free and overall survival. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 20, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

FDA Approves Two Vonoprazan Therapies for H pylori Eradication FDA Approves Two Vonoprazan Therapies for H pylori Eradication
Vonoprazan-based dual and triple regimens showed superior eradication rates compared with PPI-based triple therapy in a pivotal trial.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 4, 2022 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news

Two New Regimens Win FDA Approval for H. Pylori Infection
(MedPage Today) -- The FDA approved two vonoprazan-based regimens, one with amoxicillin and clarithromycin (Voquezna Triple Pak), and one with amoxicillin (Voquezna Dual Pak), to treat Helicobacter pylori (H. pylori) infection in adults, drugmaker... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 4, 2022 Category: American Health Source Type: news

FDA Approves Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults
Voquezna Triple and Dual Paks each contain vonoprazan, a novel, first-in-class potassium-competitive acid blocker (PCAB), and have demonstrated superior eradication rates vs. lansoprazole-based triple therapy in the overall... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 4, 2022 Category: Drugs & Pharmacology Source Type: news